Poster Exhibition 1

[PE-061] Guselkumab efficacy and safety in East Asian participants with moderate to severely active ulcerative colitis: Subgroup analysis of the Phase 2b/3 QUASAR induction and maintenance studies

Baili Chen¹, Byong Duk Ye², Qian Cao³, Fumihito Hirai⁴, *Masayuki Saruta⁵, Minhu Chen¹, Susan Pelak⁶, Nicole Shipitofsky⁶, Brian Wahking⁷, Jianmin Zhou⁸, Tadakazu Hisamatsu⁹ (1. The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, 2. University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, 3. Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China, 4. Fukuoka University Hospital, Fukuoka, Japan, 5. The Jikei University School of Medicine, Tokyo, Japan, 6. Janssen Research & Development, LLC, Spring House, PA, USA, 7. Janssen Asia Pacific, Singapore , 8. Janssen China R&D, Shanghai, China, 9. Kyorin University School of Medicine, Tokyo, Japan)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.